Literature DB >> 10484614

Mice lacking acylation stimulating protein (ASP) have delayed postprandial triglyceride clearance.

I Murray1, A D Sniderman, K Cianflone.   

Abstract

Acylation stimulating protein (ASP) is a 76 amino acid fragment of the third component of complement (C3) which is generated by the interaction of adipsin and factor B with C3. In vitro studies have shown that ASP can markedly increase triglyceride synthesis in adipocytes. To test the ASP pathway in vivo, C3-deficient mice, and therefore ASP-deficient mice, were generated and oral fat loads were conducted in wild-type (C3+/+) and mutant (C3-/-) animals. The principal results were: 1) postprandial triglyceride clearance was significantly delayed in mutant compared to wild-type mice; 2) this difference was more pronounced in males compared to females; 3) in both males and females, the differences were more pronounced in the second half of the postprandial period; 4) fasting and postprandial free fatty acid (FFA) were higher in C3(-/-) than in C3(+/+) males; and 5) intraperitoneal administration of ASP accelerated triglyceride clearance in C3(-/-) males. The data are consistent therefore, with the hypothesis that the ASP pathway is an important physiologic determinant of normal postprandial triglyceride clearance.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10484614

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  15 in total

Review 1.  Postprandial lipemia and coronary risk.

Authors:  W Patsch; H Esterbauer; B Föger; J R Patsch
Journal:  Curr Atheroscler Rep       Date:  2000-05       Impact factor: 5.113

Review 2.  Mechanisms of nutritional and hormonal regulation of lipogenesis.

Authors:  S Kersten
Journal:  EMBO Rep       Date:  2001-04       Impact factor: 8.807

Review 3.  The role of complement system in adipose tissue-related inflammation.

Authors:  Sonia I Vlaicu; Alexandru Tatomir; Dallas Boodhoo; Stefan Vesa; Petru A Mircea; Horea Rus
Journal:  Immunol Res       Date:  2016-06       Impact factor: 2.829

Review 4.  Adipocyte-derived hormones, cytokines, and mediators.

Authors:  Cristina M Rondinone
Journal:  Endocrine       Date:  2006-02       Impact factor: 3.633

5.  Transcriptomic evidence that cortisol alters perinatal epicardial adipose tissue maturation.

Authors:  Elaine M Richards; Emily McElhaney; Katelyn Zeringue; Serene Joseph; Maureen Keller-Wood
Journal:  Am J Physiol Endocrinol Metab       Date:  2019-07-19       Impact factor: 4.310

6.  The effects of acylation stimulating protein supplementation VS antibody neutralization on energy expenditure in wildtype mice.

Authors:  Sabina Paglialunga; Alexandre Fisette; Mercedes Munkonda; Ying Gao; Denis Richard; Katherine Cianflone
Journal:  BMC Physiol       Date:  2010-04-23

7.  IgG is elevated in obese white adipose tissue but does not induce glucose intolerance via Fcγ-receptor or complement.

Authors:  A D van Dam; L van Beek; A C M Pronk; S M van den Berg; J Van den Bossche; M P J de Winther; F Koning; C van Kooten; P C N Rensen; M R Boon; J S Verbeek; K Willems van Dijk; V van Harmelen
Journal:  Int J Obes (Lond)       Date:  2017-08-30       Impact factor: 5.095

8.  A complement-dependent balance between hepatic ischemia/reperfusion injury and liver regeneration in mice.

Authors:  Songqing He; Carl Atkinson; Fei Qiao; Katherine Cianflone; Xiaoping Chen; Stephen Tomlinson
Journal:  J Clin Invest       Date:  2009-07-20       Impact factor: 14.808

9.  CD55 deficiency protects against atherosclerosis in ApoE-deficient mice via C3a modulation of lipid metabolism.

Authors:  Ruth D Lewis; Mark J Perry; Irina A Guschina; Christopher L Jackson; B Paul Morgan; Timothy R Hughes
Journal:  Am J Pathol       Date:  2011-08-02       Impact factor: 4.307

10.  The C3a anaphylatoxin receptor is a key mediator of insulin resistance and functions by modulating adipose tissue macrophage infiltration and activation.

Authors:  Yaël Mamane; Chi Chung Chan; Genevieve Lavallee; Nicolas Morin; Li-Jing Xu; JingQi Huang; Robert Gordon; Winston Thomas; John Lamb; Eric E Schadt; Brian P Kennedy; Joseph A Mancini
Journal:  Diabetes       Date:  2009-07-06       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.